{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:32:22Z","timestamp":1777984342643,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T00:00:00Z","timestamp":1772841600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"DOI":"10.1186\/s12902-026-02228-8","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T09:05:40Z","timestamp":1772874340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated parathyroid hormone levels in normocalcemic patients after parathyroidectomy for primary hyperparathyroidism: what risk factors should be considered?"],"prefix":"10.1186","volume":"26","author":[{"given":"Jun","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuo","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pingping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xili","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanwen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haohao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4782-3982","authenticated-orcid":false,"given":"Xinhui","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,7]]},"reference":[{"issue":"2","key":"2228_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2017.104","volume":"14","author":"MD Walker","year":"2018","unstructured":"Walker MD, Silverberg SJ. Primary hyperparathyroidism. Nat Rev Endocrinol. 2018;14(2):115\u201325.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"2228_CR2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"Yeh MW, Ituarte PH, Zhou HC, Nishimoto S, Liu IL, Harari A, et al. Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J Clin Endocrinol Metab. 2013;98(3):1122\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2228_CR3","doi-asserted-by":"publisher","first-page":"16033","DOI":"10.1038\/nrdp.2016.33","volume":"2","author":"JP Bilezikian","year":"2016","unstructured":"Bilezikian JP, Cusano NE, Khan AA, Liu JM, Marcocci C, Bandeira F. Primary hyperparathyroidism. Nat Rev Dis Primers. 2016;2(1):16033.","journal-title":"Nat Rev Dis Primers"},{"key":"2228_CR4","doi-asserted-by":"crossref","unstructured":"Bilezikian JP, Brandi ML, Eastell R, Silverberg SJ, Udelsman R, Marcocci C, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99(10):3561\u20133569.","DOI":"10.1210\/jc.2014-1413"},{"key":"2228_CR5","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/SLA.0b013e318208fed9","volume":"253","author":"R Udelsman","year":"2011","unstructured":"Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg. 2011;253:585\u201391.","journal-title":"Ann Surg"},{"issue":"3","key":"2228_CR6","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00405-017-4836-9","volume":"275","author":"R de la Plaza Llamas","year":"2018","unstructured":"de la Plaza Llamas R, Ramia A\u00b4 ngel JM, Arteaga Peralta V, Garc\u00b4\u0131a Amador C, Lo\u00b4 pez Marcano AJ, et al. Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review. Eur Arch Otorhinolaryngol. 2018;275(3):659\u201369.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2228_CR7","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.surg.2011.09.017","volume":"150","author":"M Goldfarb","year":"2011","unstructured":"Goldfarb M, Gondek S, Irvin GL III, Lew JI. Normocalcemic parathormone elevation after successful parathyroidectomy: long-term analysis of parathormone variations over 10 years. Surgery. 2011;150:1076\u201382.","journal-title":"Surgery"},{"key":"2228_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/SLA.0b013e31819a6ded","volume":"249","author":"L Ning","year":"2009","unstructured":"Ning L, Sippel R, Schaefer S, Chen H. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism? Ann Surg. 2009;249:469\u201372.","journal-title":"Ann Surg"},{"key":"2228_CR9","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archsurg.143.7.659","volume":"143","author":"CC Solorzano","year":"2008","unstructured":"Solorzano CC, Mendez W, Lew JI, Rodgers SE, Montano R, Carneiro-Pla DM, et al. Long-term outcome of patients with elevated parathyroid hormone levels after successful parathyroidectomy for sporadic primary hyperparathyroidism. Arch Surg. 2008;143:659\u201363.","journal-title":"Arch Surg"},{"key":"2228_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1245\/s10434-011-1846-5","volume":"1","author":"BH Lang","year":"2012","unstructured":"Lang BH, Wong IY, Wong KP, Lo C. Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome. Ann Surg Oncol. 2012;1:584\u201390.","journal-title":"Ann Surg Oncol"},{"key":"2228_CR11","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.surg.2005.08.026","volume":"138","author":"TS Wang","year":"2005","unstructured":"Wang TS, Ostrower ST, Heller KS. Persistently elevated parathyroid hormone levels after parathyroid surgery. Surgery. 2005;138:1130\u20135.","journal-title":"Surgery"},{"issue":"6","key":"2228_CR12","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1067\/msy.2002.128479","volume":"132","author":"SE Carty","year":"2002","unstructured":"Carty SE, Roberts MM, Virji MA, Haywood L, Yim JH. Elevated serum parathormone level after concise parathyroidectomy for primary sporadic hyperparathyroidism. Surgery. 2002;132(6):1086\u201392.","journal-title":"Surgery"},{"issue":"1","key":"2228_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9610(01)00664-X","volume":"182","author":"A Denizot","year":"2001","unstructured":"Denizot A, Pucini M, Chagnaud C, Botti G, Henry JF. Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg. 2001;182(1):15\u20139.","journal-title":"Am J Surg"},{"issue":"11","key":"2228_CR14","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s002680010219","volume":"24","author":"J Westerdahl","year":"2000","unstructured":"Westerdahl J, Valdemarsson S, Lindblom P, Bergenfelz A. Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption. World J Surg. 2000;24(11):1323\u20139.","journal-title":"World J Surg"},{"issue":"6","key":"2228_CR15","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.surg.2007.01.025","volume":"141","author":"TD Beyer","year":"2007","unstructured":"Beyer TD, Solorzano CC, Prinz RA, Babu A, Nilubol N, Patel S. Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery. 2007;141(6):777\u201383.","journal-title":"Surgery"},{"issue":"6","key":"2228_CR16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00268-004-7124-y","volume":"28","author":"E Nordenstr\u00f6m","year":"2004","unstructured":"Nordenstr\u00f6m E, Westerdahl J, Bergenfelz A. Long-term follow-up of patients with elevated PTH levels following successful exploration for primary hyperparathyroidism. World J Surg. 2004;28(6):570\u20135.","journal-title":"World J Surg"},{"issue":"4","key":"2228_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.surg.2016.10.021","volume":"161","author":"OA Lavryk","year":"2017","unstructured":"Lavryk OA, Siperstein AE. Pattern of calcium and parathyroid hormone normalization at 12-months follow-up after parathyroid operation. Surgery. 2017;161(4):1139\u201348.","journal-title":"Surgery"},{"key":"2228_CR18","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.surg.2004.12.009","volume":"137","author":"H Yamashita","year":"2005","unstructured":"Yamashita H, Noguchi S, Moriyama T, Takamatsu Y, Sadanaga K, Uchino S, et al. Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: Importance of decreased renal parathyroid hormone sensitivity. Surgery. 2005;137:419\u201325.","journal-title":"Surgery"},{"key":"2228_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1001\/archotol.128.3.275","volume":"128","author":"EA Mittendorf","year":"2002","unstructured":"Mittendorf EA, McHenry CR. Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg. 2002;128:275\u20139.","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"2228_CR20","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.surg.2005.09.018","volume":"138","author":"ZA Stewart","year":"2005","unstructured":"Stewart ZA, Blackford A, Somervell H, Friedman K, Garrett-Mayer E, Dackiw AP, et al. 25-hydroxyvitamin D deffciency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery. 2005;138:1018\u201325.","journal-title":"Surgery"},{"key":"2228_CR21","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.metabol.2004.04.003","volume":"53","author":"KS Dhillon","year":"2004","unstructured":"Dhillon KS, Cohan P, Darwin C, Van Herle A, Chopra IJ. Elevated serum parathyroid hormone concentration in eucalcemic patients after parathyroidectomy for primary hyperparathyroidism and its relationship to vitamin D profile. Metabolism. 2004;53:1101\u20136.","journal-title":"Metabolism"},{"key":"2228_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/S0039-6060(96)80186-3","volume":"119","author":"A Bergenfelz","year":"1996","unstructured":"Bergenfelz A, Valdemarsson S, Tibblin S. Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: Evidence of detrimental effects of severe parathyroid disease. Surgery. 1996;119:624\u201333.","journal-title":"Surgery"},{"key":"2228_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jss.2007.06.009","volume":"143","author":"TD Beyer","year":"2007","unstructured":"Beyer TD, Chen EL, Nilubol N, Prinz RA, Solorzano CC. Short-term outcomes of parathyroidectomy in patients with or without 25-hydroxy vitamin D insufffciency. J Surg Res. 2007;143:145\u201350.","journal-title":"J Surg Res"},{"key":"2228_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s00268-002-6600-5","volume":"27","author":"E Nordenstr\u00f6m","year":"2003","unstructured":"Nordenstr\u00f6m E, Westerdahl J, Isaksson A, Lindblom P, Bergenfelz A. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: Showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg. 2003;27:212\u20135.","journal-title":"World J Surg"},{"issue":"10","key":"2228_CR25","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1210\/jc.2019-00705","volume":"104","author":"M Caldwell","year":"2019","unstructured":"Caldwell M, Laux J, Clark M, Kim L, Rubin J. Persistently Elevated PTH After Parathyroidectomy at One Year: Experience in a Tertiary Referral Center. J Clin Endocrinol Metab. 2019;104(10):4473\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2228_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.surg.2012.07.005","volume":"152","author":"CB Carsello","year":"2012","unstructured":"Carsello CB, Yen TW, Wang TS. Persistent elevation in serum parathyroid hormone levels in normocalcemic patients after parathyroidectomy: does it matter? Surgery. 2012;152(4):575\u201381.","journal-title":"Surgery"},{"issue":"6","key":"2228_CR27","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1067\/msy.1998.92004","volume":"124","author":"AK Mandal","year":"1998","unstructured":"Mandal AK, Udelsman R. Secondary hyperparathyroidism is an expected consequence of parathyroidectomy for primary hyperparathyroidism: a prospective study. Surgery. 1998;124(6):1021\u20136.","journal-title":"Surgery"},{"issue":"1","key":"2228_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.surg.2020.05.049","volume":"169","author":"CY Ryder","year":"2021","unstructured":"Ryder CY, Jarocki A, McNeely MM, Currey E, Miller BS, et al. Early biochemical response to parathyroidectomy for primary hyperparathyroidism and its predictive value for recurrent hypercalcemia and recurrent primary hyperparathyroidism. Surgery. 2021;169(1):120\u20135.","journal-title":"Surgery"},{"issue":"3","key":"2228_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/SLA.0b013e31819a6ded","volume":"249","author":"L Ning","year":"2009","unstructured":"Ning L, Sippel R, Schaefer S, Chen H. What is the clinical significance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism? Ann Surg. 2009;249(3):469\u201372.","journal-title":"Ann Surg"},{"issue":"1","key":"2228_CR30","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/wjs.12413","volume":"49","author":"S Dream","year":"2025","unstructured":"Dream S, Kim GY, Doffek K, Yen TW, Carroll T, Shaker J, et al. Persistent elevation of parathyroid hormone after curative parathyroidectomy: A risk factor for recurrent hyperparathyroidism. World J Surg. 2025;49(1):148\u201358.","journal-title":"World J Surg"},{"issue":"5","key":"2228_CR31","doi-asserted-by":"publisher","first-page":"470","DOI":"10.4158\/EP-2018-0489","volume":"25","author":"MW Yeh","year":"2019","unstructured":"Yeh MW, Zhou H, Kuo EJ, Adams AL, Li N, Haigh PI. Biochemical dynamics of untreated primary hyperparathyroidism: an observational study. Endocr Pract. 2019;25(5):470\u20136.","journal-title":"Endocr Pract"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12902-026-02228-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02228-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-026-02228-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:33:30Z","timestamp":1776170010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12902-026-02228-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,7]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2228"],"URL":"https:\/\/doi.org\/10.1186\/s12902-026-02228-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7022277\/v1","asserted-by":"object"}]},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,7]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was carried out in accordance with the Helsinki Declaration and approved by the Ethics Committee of the First Affiliated Hospital, College of Medicine, Zhejiang University (IIT-20241294\u00a0A). Because this study was retrospective, the requirement of informed consent was waived. It was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"111"}}